Adagio Medical Holdings (ADGM) Non-Current Debt (2023)

Adagio Medical Holdings (ADGM) reported Non-Current Debt of $143000.0 for Q4 2023.

Adagio Medical Holdings (ADGM) Non-Current Debt (2023) Analysis & Trends

Adagio Medical Holdings (ADGM) has 1 years of Non-Current Debt data on file, last reported at $143000.0 in Q4 2023.

  • Non-Current Debt for Q4 2023 came in at $143000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $143000.0 (changed N/A YoY), and the FY2023 annual result was $143000.0, changed N/A from the prior year.
  • Non-Current Debt steadied at $143000.0 in Q4 2023 per ADGM's latest filing.
  • Over five years, Non-Current Debt peaked at $143000.0 in Q4 2023 and troughed at $143000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 29.64 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 14.22 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 27.88 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 10.99 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 598.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 8.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 1.81 Bn
10 Adagio Medical Holdings 15.88 Mn 2.97 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 143,000.00
Dec 31, 2023 143,000.00